Management Practices for Raynaud Phenomenon in Patients With Systemic Sclerosis
Overall use of RP medication was low with poor maintenance rates in less than one-third of the patients from this community sample. The pattern of RP medication use changed over time with increasing use of PDE5i use since 2019. Although socioeconomic factors had impact on RP medication initiation, there is also a need for education and guideline recommendations to assist community-based rheumatologists in RP management.
Authors
- Gülşen Özen (ORCID: https://orcid.org/0000-0002-5423-393X)
- Kaleb D. Michaud (ORCID: https://orcid.org/0000-0002-5350-3934)
- Robyn T. Domsic (ORCID: https://orcid.org/0000-0002-2765-0922)
- Sofia Pedro
Institutions
- University of Pittsburgh (US)
- The National Databank for Rheumatic Diseases (US)
- University of Iowa Health Care (US)
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- JCR Journal of Clinical Rheumatology
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1097/rhu.0000000000002242
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00